Graft Polymer (UK) PLC (GB:GPL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Graft Polymer (UK) PLC, a biotech firm specializing in mental health disorder therapeutics, has announced the appointment of industry veteran Dennis Purcell as its new Chairman. An interview with Purcell has been featured on Proactive Investors, highlighting the company’s mission to tackle conditions such as PTSD, which impacts millions globally. Graft Polymer’s focus is on improving treatment outcomes for these disorders, leveraging their innovative research and development strategies.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.